Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in OCULAR THERAPEUTIX INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 308,906 shares of OCUL (OCULAR THERAPEUTIX INC), worth $2.6M as of 2026-Q1. The position was increased (+0.4% shares). OCUL represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$2.6M
Current Shares
308,906
Total Value Change
+$1.3M
Total Shares Change
+122,846
Other major holders of OCUL: BNP PARIBAS FINANCIAL MARKETS, FMR LLC
Increased |
| 308,906 |
+0.4% |
| $2.6M |
| 0.0% |
| $10.76 |
26 |
| 2025-Q4 | Increased | 307,747 | +52.9% | $3.7M | 0.0% | $12.20 | 37 |
| 2025-Q3 | Decreased | 201,259 | -36.4% | $2.4M | 0.0% | $12.53 | 0 |
| 2025-Q2 | Increased | 316,276 | +48.5% | $2.9M | 0.0% | $9.22 | 36 |
| 2025-Q1 | Decreased | 212,952 | -2.6% | $1.6M | 0.0% | $7.58 | 0 |
| 2024-Q4 | Increased | 218,588 | +48.0% | $1.9M | 0.0% | $8.35 | 35 |
| 2024-Q3 | Decreased | 147,684 | -20.6% | $1.3M | 0.0% | $8.68 | 0 |
| 2024-Q2 | New | 186,060 | - | $1.3M | 0.0% | $6.84 | 35 |